Summit Therapeutics Limited

#05197494 Active

Summit Therapeutics Inc. is a biopharmaceutical oncology company dedicated to developing innovative therapies to improve the quality of life for patients with serious unmet medical needs, particularly in oncology.

Founded: 4 Aug 2004
Industries:
72110 - Research and experimental development on biotechnology
Location: Abingdon

Products & Services

• biopharmaceuticals
• biotechnology
• clinical trials
• health care
• investigational therapies
• ivonescimab (smt112)
• medical device
• oncology
• therapeutics

Financial Snapshot

Last accounts made up to 31 Dec 2024
Next accounts due 30 Sept 2026 (10 months)
Cash in Bank
£0.34m
↓ 23%
Turnover
£2.1m
↑ 15%
EBITDA
£0.45m
↑ 8%
Gross Profit
£0.89m
↑ 12%
Total Liabilities
£0.72m
↓ 17%
Employees
14
↑ 0%
Unlock financial data with Pro Start Free Trial →

People

Officers
3
Shareholders
1
Controllers (PSC)
1
Robert William Duggan
Director • American • Lives in United States • Born in Apr 1944
Manmeet Singh Soni
Director • American • Lives in United States • Born in Nov 1977
Bhaskar Anand
Director • American • Lives in United States • Born in Jun 1977

Registered Office Address

136a Eastern Avenue

Milton Park

Abingdon

OX14 4SB

United Kingdom

Basic Information

LTD
4 Aug 2004
ENGLAND WALES
Yes

Industry Classification

72110

Company Attributes

N/A
N/A
N/A
N/A

Summary

44
Officers
1
PSCs
0
Filings